Chapter
The Final Phase of Vaccine Development
35:45 - 45:31 (09:45)
In the final phase of vaccine development, sponsors and pharmaceutical companies need to allow for an unbiased study to be conducted with a large number of participants to determine the efficacy and safety of the vaccine. This can be hindered by sponsor influence and the time it takes to conduct the study.
Clips
The speaker discusses the implicit pressure that comes with sponsorship from large companies like Pfizer and how it could potentially hinder the best of human nature.
35:45 - 38:11 (02:25)
Summary
The speaker discusses the implicit pressure that comes with sponsorship from large companies like Pfizer and how it could potentially hinder the best of human nature.
ChapterThe Final Phase of Vaccine Development
Episode#249 – Albert Bourla: Pfizer CEO
PodcastLex Fridman Podcast
This episode discusses the complicated process of developing and testing vaccines, including the multiple phases of clinical trials that are involved and the various factors that need to be taken into account.
38:11 - 43:01 (04:50)
Summary
This episode discusses the complicated process of developing and testing vaccines, including the multiple phases of clinical trials that are involved and the various factors that need to be taken into account.
ChapterThe Final Phase of Vaccine Development
Episode#249 – Albert Bourla: Pfizer CEO
PodcastLex Fridman Podcast
Pfizer was able to streamline their vaccine production process by reducing the number of hospitals involved in recruitment and focusing on their normal manufacturing production of 200 million vaccine doses annually.
43:03 - 45:31 (02:27)
Summary
Pfizer was able to streamline their vaccine production process by reducing the number of hospitals involved in recruitment and focusing on their normal manufacturing production of 200 million vaccine doses annually.